Terms/Glossary

News & Events

Skriv ut

News & Events - Clavis Pharma press releases

8 February 2012
Fourth Quarter Results 2011

2 February 2012
Invitation to presentation and webcast of Clavis Pharma's fourth quarter results 2011

18 January 2012
CLAVIS PHARMA: Raises NOK 163 million in a private placement

17 January 2012
Clavis Pharma – Update regarding Phase III CLAVELA trial

9 January 2012
Clavis Pharma announces size of initial hENT1-low population in pivotal LEAP trial with CP-4126

12 December 2011
Promising interim results of Phase II trial with elacytarabine in combination with idarubicin in patients with early stage acute myeloid leukaemia (AML) presented at ASH annual meeting

28 October 2011
Clavis Pharma’s Financial Calendar 2012

27 October 2011
Clavis Pharma Third Quarter 2011

24 October 2011
Clavis Pharma announces the completion of Study 002 Low hENT1 cut-off level determined for pivotal LEAP study of CP-4126 in patients with pancreatic cancer

20 October 2011
Invitation to presentation and webcast of Clavis Pharma's third quarter results 2011